The stereoselective distribution of halofantrine enantiomers within human, dog, and rat plasma lipoproteins.
OBJECTIVE
To study the in vitro distribution of the enantiomers of the antimalarial drug halofantrine in human, dog and rat plasma lipoprotein-fractions.


METHODS
Plasma was spiked with racemic halofantrine (1,000 ng/ml) and incubated for 1 h at 37 degree C. The fractions (high and low density lipoproteins, triglyceride-rich lipoproteins and lipoprotein deficient plasma) were separated using density gradient ultracentrifugation. Fractions were assayed for halofantrine enantiomer using stereospecific high performance liquid chromatography.


RESULTS
The (-) enantiomer of halofantrine displayed higher affinity for the lipoprotein-deficient fraction than the (+) enantiomer in all three species. The (+) enantiomer was predominately located in the lipoprotein rich fractions of dog and human plasma (the (+):(-) ratio ranging from 1.2-9.6). In contrast, the (+):(-) ratio was consistently < 1 in lipoprotein-deficient fractions. Dog displayed a large magnitude of stereoselectivity in halofantrine distribution to the plasma fractions tested. There were substantial interspecies differences in the pattern of distribution of halofantrine enantiomers within the different fractions. A significant positive relationship was observed between halofantrine uptake into lipoprotein-rich fractions and the percent of apolar core lipid in those fractions. There was also a strong negative correlation between total protein concentration and the enantiomeric ratio in the lipoprotein-deficient plasma fraction.


CONCLUSIONS
Distribution of halofantrine enantiomer to plasma lipoprotein-fractions is stereoselective and species specific. This differential binding of halofantrine enantiomers to lipoproteins may need to be considered in viewing pharmacokinetic and pharmacodynamic data involving the drug.
Brocks
D R
DR
Western University of Health Sciences, College of Pharmacy, Pomona, California 91766-1854, USA. dbrocks@westernu.edu
Ramaswamy
M
M
MacInnes
A I
AI
Wasan
K M
KM
D000818:Animals; D000962:Antimalarials / Q000097:blood / Q000493:pharmacokinetics*; D004285:Dogs; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D010616:Phenanthrenes / Q000097:blood / Q000493:pharmacokinetics*; D051381:Rats; D013237:Stereoisomerism
D000962:Antimalarials; D008074:Lipoproteins; D010616:Phenanthrenes; C023768:halofantrine